Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 1, 2011, Pages 27-32

  Roughead, E E ^a   Barratt, J D ^a   Ramsay, E ^b   Pratt, N ^b   Ryan, P ^b   Peck, R ^c   Killer, G ^c   Gilbert, A L ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Department of Veterans' Affairs ^*  (Australia)

Author keywords

home based team care; medication review; warfarin related bleeding

Indexed keywords

WARFARIN;

AGED; ARTICLE; AUSTRALIA; BLEEDING; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FOLLOW UP; GENERAL PRACTITIONER; HOME CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICINE; OUTCOME ASSESSMENT; PHARMACIST; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDY; VETERAN; WAR;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AUSTRALIA; COHORT STUDIES; FAMILY HEALTH; FEMALE; GENERAL PRACTITIONERS; HEMORRHAGE; HOSPITALIZATION; HOUSE CALLS; HUMANS; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHARMACISTS; RETROSPECTIVE STUDIES; TIME FACTORS; VETERANS; WARFARIN;

EID: 78649925961     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01149.x     Document Type: Article

References (24)

1. Hart RG, Pearce LA, Aguilar MI, (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine, 146, 857-867.
2. Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC, (2006) The risks of warfarin use in the elderly. Expert Opinion on Drug Safety, 5, 417-431.
3. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S, (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation, 115, 2689-2696.
4. Runciman WB, Roughead EE, Semple SJ, Adams RJ, (2003) Adverse drug events and medication errors in Australia. International Journal for Quality in Health Care, 15 (Suppl. 1), i49-i59.
5. Hughes M, Lip GY, (2007) Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM, 100, 599-607.
6. DiMarco JP, Flaker G, Waldo AL, et al. (2005) Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. American Heart Journal, 149, 650-656.
7. Delaney JA, Opatrny L, Brophy JM, Suissa S, (2007) Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ, 177, 347-351.
8. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S, (2004) Safety of anticoagulation therapy in well-informed older patients. Archives of Internal Medicine, 164, 2044-2050.
9. Medi C, Hankey GJ, Freedman SB, (2007) Atrial fibrillation. Medical Journal of Australia, 186, 197-202.
10. Gallus AS, Baker RI, Chong BH, Ockelford PA, Street AM, (2000) Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis. Medical Journal of Australia, 172, 600-605.
11. Australian Medicines Handbook Pty Ltd. (2008) Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd.
12. Harrison J, (2008) Managing variability in warfarin dosing: drugs, diseases and diets. New Zealand Family Physician, 35, 116-121.
13. Jackson SL, Peterson GM, Vial JH, Jupe DM, (2004) Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation. Journal of Internal Medicine, 256, 137-144.
14. Pharmacy Guild of Australia (2009) Medication Management Review Program. Canberra: Pharmacy Guild of Australia. Available at: (accessed 24 April 2009).
15. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD, (2002) Collaborative medication management services: improving patient care. Medical Journal of Australia, 177, 189-192.
16. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK, (2008) Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 65, 303-316.
17. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT, (2008) Pharmacist care of patients with heart failure: a systematic review of randomized trials. Archives of Internal Medicine, 168, 687-694.
18. World Health Organization Collaborating Centre for Drug Statistics Methodology (2008) Anatomical Therapeutic Chemical Code Classification index with Defined Daily Doses. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology.
19. Australian Government Department of Health and Ageing (2008) Schedule of Pharmaceutical Benefits. Canberra: National Capital Printing.
20. World Health Organization (2002) International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: World Health Organization.
21. Australian Bureau of Statistics (ABS) (2001) Information Paper: Census of Population and Housing. Socio-economic indexes for areas, Australia, Canberra: ABS; 2003.
22. Australian Institute of Health and Welfare A (2004) Rural, Regional and Remote Health. A Guide to Remoteness Classifications. AIHW catalogue number PHE 53. Canberra: AIHW.
23. Vitry A, Wong S, Roughead EE, Ramsay E, Barratt J, (2009) Validity of medication-based comorbidity indices in the Australian elderly population. Australian and New Zealand Journal of Public Health, 33, 126-130.
24. Australian Institute of Health and Welfare A (2002) Health Care Usage and Costs. A Comparison of Veterans and War Widows and Widowers with the Rest of the Community. Canberra: AIHW.